Scarica l'app Stockscreener
16.05
0.31%
-0.05
Vogenx Inc Common Stock Borsa (VOGX) Ultime notizie
Vogenx Director Peter Pieraccini Granted 50,000 Stock Options at $18.23 Exercise Price - Kalkine Media
155,000 options for Vogenx (VOGX) science chief vest over three years, subject to continued service. - Stock Titan
A director receives 50,000 Vogenx (VOGX) stock options with an $18.23 exercise price. - Stock Titan
Options priced at $18.23 go to Vogenx (VOGX) CFO Steven R. Delmar in a 155,000-option grant. - Stock Titan
Vogenx Director Kenneth John Toombs Submits Initial Form 3 Reporting No Securities Ownership - Kalkine Media
IPO cash gives Vogenx (VOGX) runway amid losses and control weaknesses - Stock Titan
One asset manager group now reports 13% of Vogenx (VOGX) - Stock Titan
Vogenx (VOGX) insiders report 700,000-share stake in new filing - Stock Titan
Vogenx (NASDAQ: VOGX) CFO holds 700K shares plus options - Stock Titan
Vogenx (VOGX) CEO details 1.8M-share stake and option grants - Stock Titan
Vogenx (VOGX) CSO reports options plus 1.8M indirect shares - Stock Titan
Vogenx (VOGX) director holds stock options out to 2036 - Stock Titan
Vogenx (VOGX) director details $0.93–$1.20 stock options - Stock Titan
Vogenx Strengthens Capital Base With IPO Over-Allotment - TipRanks
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - PR Newswire
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - Nasdaq
Vogenx Announces Closing of Initial Public Offering - Yahoo Finance
Vogenx closes $81.3M IPO at $13 per share, lists on Nasdaq - scanx.trade
Vogenx, Clinical-Stage Biopharmaceutical Developer, Files for NASDAQ IPO - TradingView
Vogenx, Inc. (VOGX) Stock Price, News, Quote & History - Yahoo Finance
Vogenx (VOGX) director reports 26,665 options, 42,735-share note - Stock Titan
VOGX SEC Filings, Aug 12, 2026Vogenx, Inc. Filing Archive - Stock Titan
Vogenx Announces Pricing of Initial Public Offering - Yahoo Finance
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive
Vogenx, Clinical-Stage Metabolic Disease Therapeutics, Files for Nasdaq Capital Market IPO - TradingView
Vogenx Announces Initial Public Offering Of Common StockSEC Filing - TradingView
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):